Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/04/065969
CTRI/2024/04/065969
Not yet recruiting
Phase 3

A clinical evaluation of severity and management of peri-implantitis around dental implant in post COVID 19 patients- Randomized control trial - NI

Council of Science and Technology U P0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: T857- Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: T857- Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
Sponsor
Council of Science and Technology U P
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Council of Science and Technology U P

Eligibility Criteria

Inclusion Criteria

  • •Post covid\-19 healthy subjects will be recruited who have SPO2, Pulse rate, Blood pressure within standard limits.
  • •Ability to understand the procedure and provide informed consent assessed by decision making capacity and approaches before being included in the study.
  • •Diagnosis of peri\-implantitis based on the soft tissue around the implant showing obvious inflammatory symptoms, bone loss revealed by X\-ray examination and probable haemorrhage and suppuration.
  • •At least 2 implant site with periodontal PD \=4\- 6 mm.
  • •Plaque Index around the implant \= 2 points
  • •Visible bleeding around the implant after probing.
  • •CAL \= 3 mm.

Exclusion Criteria

  • •Current smoking habit with moderate or heavy smoking (more than 10 cigarettes per day) or chewing tobacco.
  • •History of drug abuse or alcoholism within the past 5 years
  • •Severe bruxism or clenching habit.
  • •Significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area.
  • •History of systemic disease that precludes standard dental implant therapy.
  • •Past history of implant repair and failure over past 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Diagnosis, severity assessment, and therapy evaluation of amyloidosis using amyloid PET imaiging (Continued study from 2020)amyloidosis
JPRN-UMIN000042176Shinshu University100
Recruiting
Not Applicable
Evaluation of Anxiety Online: A public online mental health serviceanxiety disordersMental Health - Anxiety
ACTRN12611000704998ational eTherapy Centre and BPsyC eTherapy Research Unit, Swinburne University20,000
Not yet recruiting
Not Applicable
A naturalistic evaluation of the use of Anxiety Online by clients of a national provider of employment servicesAnxiety disordersDepressionMental Health - AnxietyMental Health - Depression
ACTRN12612001046897ational eTherapy Centre and BPsyC eTherapy Research Unit, Swinburne University100
Not yet recruiting
Phase 2
STUDY ON SIDDHA MEDICINE TO MANAGE AND TREAT MENTAL AND BEHAVIOURAL PROBLEMS IN CHILDREHealth Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
CTRI/2019/12/022286ational Institute of Siddha
Completed
Phase 3
thaamani Nei(Internal) and Nellikkai thylam (External) in the management of Mantha Sanni (Autism spectrum disorder)
CTRI/2021/08/035524ational Institute of Siddha